Hint mode is switched on Switch off

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access
×

— Are you looking for complete & verified bond data?

— We have everything
you need:

  • full data on over 700 000 bonds, stocks & ETFs;
  • powerful bond screener;
  • over 350 pricing sources among stock exchanges & OTC market;
  • ratings & financial reports;
  • user-friendly interface;
  • available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 652K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

S&P Global Ratings upgrades Local Currency LT credit rating of AstraZeneca to "A" from "A-"; outlook stable

November 28, 2022 Cbonds
Show full article
This functionality is available for registred users only
Company — AstraZeneca
  • Full name
    Astrazeneca Plc
  • Registration country
    United Kingdom
  • Industry
    Pharmaceutical Preparation and Biotechnology

Other Company's News

Registration is required to get access.